Tenet Healthcare Corporation $THC Shares Bought by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC grew its position in Tenet Healthcare Corporation (NYSE:THC) by 1.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 126,320 shares of the company’s stock after buying an additional 1,509 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Tenet Healthcare were worth $22,232,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. US Bancorp DE lifted its position in shares of Tenet Healthcare by 0.8% during the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock worth $1,159,000 after purchasing an additional 68 shares in the last quarter. Farther Finance Advisors LLC boosted its position in Tenet Healthcare by 2.8% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company’s stock valued at $460,000 after buying an additional 70 shares during the period. Lindbrook Capital LLC grew its stake in shares of Tenet Healthcare by 5.3% in the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock worth $192,000 after acquiring an additional 72 shares in the last quarter. Signaturefd LLC raised its stake in shares of Tenet Healthcare by 11.2% in the second quarter. Signaturefd LLC now owns 732 shares of the company’s stock valued at $129,000 after acquiring an additional 74 shares in the last quarter. Finally, Vista Investment Partners LLC boosted its holdings in Tenet Healthcare by 0.3% in the second quarter. Vista Investment Partners LLC now owns 25,257 shares of the company’s stock valued at $4,445,000 after purchasing an additional 76 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Christopher S. Lynch sold 3,952 shares of Tenet Healthcare stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $176.39, for a total value of $697,093.28. Following the transaction, the director directly owned 12,358 shares of the company’s stock, valued at $2,179,827.62. The trade was a 24.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider R. Scott Ramsey sold 13,322 shares of the stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total transaction of $2,732,475.42. The SEC filing for this sale provides additional information. Insiders have sold a total of 134,044 shares of company stock worth $25,977,997 over the last ninety days. 0.81% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on THC shares. JPMorgan Chase & Co. increased their price target on Tenet Healthcare from $190.00 to $200.00 and gave the company an “overweight” rating in a research report on Monday, August 4th. Raymond James Financial set a $245.00 target price on shares of Tenet Healthcare in a report on Wednesday, October 29th. Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Saturday, July 26th. Wells Fargo & Company lifted their price objective on shares of Tenet Healthcare from $200.00 to $238.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, Robert W. Baird dropped their target price on Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $226.25.

Tenet Healthcare Trading Up 0.4%

NYSE THC opened at $204.99 on Friday. The firm’s fifty day moving average price is $198.15 and its 200 day moving average price is $176.14. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $217.43. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. The company has a market capitalization of $18.02 billion, a price-to-earnings ratio of 14.05, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.33 by $0.37. The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. Tenet Healthcare’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.93 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.